Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX40 Omacetaxine mepesuccinate
D08956 Omacetaxine mepesuccinate (USAN)
USP drug classification [BR:br08302]
Antineoplastics
Antineoplastics, Other
Antineoplastics, Miscellaneous
Omacetaxine Mepesuccinate
D08956 Omacetaxine mepesuccinate (USAN)
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Genetic information processing
Transcription factor
MYC
D08956 Omacetaxine mepesuccinate (USAN)
Cellular process
Cell cycle
CCND1
D08956 Omacetaxine mepesuccinate (USAN)
Apoptosis
MCL1
D08956 Omacetaxine mepesuccinate (USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D08956
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08956
Pharmacogenomic biomarkers [br08341.html]
Somatic variations in targeted cancer therapies
D08956